Waldthaler Alexander, Rutkowski Wiktor, Valente Roberto, Arnelo Urban, Löhr J-Matthias
Department of Upper Abdominal Diseases at Karolinska University Hospital, and Clinical Science, Intervention and Technology (CLINTEC), Karolinska University Hospital, Stockholm, Sweden.
Transl Gastroenterol Hepatol. 2019 Jan 31;4:7. doi: 10.21037/tgh.2019.01.05. eCollection 2019.
Interventional treatment with stents in pancreatic cancer is a topic that developed during recent years and new fields of palliative stent therapy have evolved. The increasing life expectancy of patients with unresectable pancreatic cancer increases the need for clinical and cost effective therapeutic interventions. Current literature, guidelines, practice and evidence were reviewed. Besides the most obvious biliary stenting via endoscopic retrograde cholangiopancreatography (ERCP), pancreatic and gastroduodenal stenting as well as percutaneous transhepatic cholangiography (PTC) and the rapidly growing field of endosonographic stent implantation in the palliative care of patients with pancreatic cancer are being discussed from several points of view in this review.
胰腺癌的支架介入治疗是近年来发展起来的一个领域,姑息性支架治疗的新领域也不断涌现。不可切除胰腺癌患者预期寿命的延长,增加了对临床及性价比高的治疗干预措施的需求。本文回顾了当前的文献、指南、实践及证据。除了通过内镜逆行胰胆管造影术(ERCP)进行最常见的胆道支架置入外,本文还从多个角度探讨了胰腺癌患者姑息治疗中胰腺和胃十二指肠支架置入、经皮肝穿刺胆管造影术(PTC)以及快速发展的内镜超声引导下支架植入领域。